That sounds like fascinating research. Besides chemotoxic agents, do you know what other compounds are being experimented with, in combination with DCA?
Papers it discusses include:
* Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy – Lizzia Raffaghello, Valter Longo et al. (2008)
https://www.dropbox.com/sh/wmq7q6azyzfsubm/AACoCigKOQYxthruL...
* The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study – Stefanie de Groot et al. (2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595051/
* The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study – Bauersfeld et al (2018)
https://www.ncbi.nlm.nih.gov/pubmed/29699509
There's an impressive body of research on this subject already, it's just unfortunate that many (most?) oncologists haven't caught up yet with the science.
A common objection is that chemotherapy causes weight loss, and it's important that patients keep their weight up. Where this argument falls down, is when you look at why chemo patients lose weight - and it's primarily due to the treatment reducing their appetite.
So if you're then able to reduce side effects of chemo (which it appears fasting does), patients are then more easily able to eat and maintain/recover their weight.